Transdermal delivery apparatus

• US 5,980,934 A
• Filed: 05/19/1997
• Issued: 11/09/1999
• Est. Priority Date: 05/19/1997
• Status: Expired due to Fees

• Current Assignee: William Reber LLC
• Original Assignee: Motorola, Inc. (Motorola Solutions, Inc.)
• Inventors: Reber, William L., Perttunen, Cary D., Toler, Jeffrey G.
• Primary Examiner(s): Dees, Jose' G.
• Assistant Examiner(s): Shelborne, Kathryne E.
• Application Number:
  US08/858,677
• Time in Patent Office: 904 Days
• Field of Search: 424/443, 424/447, 424/449
• US Class Current: 424/449
• CPC Class Codes: A61K 41/0047 Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

In accordance with a first aspect, a noninvasive apparatus comprises a card-shaped housing which supports the transdermal delivery device (10). In accordance with a second aspect, a retaining member (18) retains a removable member (16) proximate to at least a portion of the transdermal delivery device (10). In accordance with a third aspect, a transdermal delivery apparatus comprises a processor (24) to receive delivery data via an interface (28) and to direct a transdermal delivery device (10) based upon the delivery data.

Claims

1. An apparatus comprising:

a PCMCIA card housing; and

a transdermal delivery device supported by the PCMCIA card housing.

2. The apparatus of claim 1 further comprising a member in communication with at least a portion of the transdermal delivery device, the member supporting a transdermally-deliverable substance.

3. The apparatus of claim 2 wherein the member covers at least a portion of the transdermal delivery device.

4. The apparatus of claim 2 wherein the member includes a pad.

5. The apparatus of claim 2 wherein the transdermally-deliverable substance includes at least one of a pharmaceutical material, a protein, and a hormone.

6. The apparatus of claim 1 wherein the transdermal delivery device includes an ultrasonic emitter.

7. The apparatus of claim 1 wherein the PCMCIA card housing includes a resilient portion.

8. The apparatus of claim 7 wherein the resilient portion supports at least a portion of the transdermal delivery device.

9. An apparatus comprising:

a transdermal delivery device;

an interface; and

a processor to receive substance identification data via the interface and to direct the transdermal delivery device to inhibit transdermal delivery of an inappropriate substance based upon the substance identification data.

10. The apparatus of claim 9 wherein the interface is selected from the group consisting of a PCMCIA interface, a serial interface, a parallel interface, a SCSI interface, an infrared interface, a smart card interface, and a radio frequency transceiver.

14. The apparatus of claim 9 further comprising:

removable member supporting the inappropriate substance; and

an identifier device supported by the removable member, the identifier device to identify the inappropriate substance to the processor.

15. The apparatus of claim 14 further comprising at least one electrode coupled to the processor, the at least one electrode to couple with the identifier device.

16. The apparatus of claim 9 wherein the inappropriate substance includes at least one of a pharmaceutical material, a protein, and a hormone.

17. The apparatus of claim 9 wherein the interface comprises a PCMCIA interface.

18. The apparatus of claim 9 wherein the interface comprises a smart card interface.

11. An apparatus comprising:

a housing having a grasping region; and

a transdermal delivery device to transdermally deliver a substance to a hand, finger, or thumb of an end user at the grasping region.

12. The apparatus of claim 11 wherein the transdermal delivery device includes an ultrasonic emitter.

13. The apparatus of claim 11 further comprising a thermoelectric cooling member to draw heat from the substance.

19. An apparatus comprising:

a credit-card-like housing; and

a transdermal delivery device supported by the credit-card-like housing.

20. The apparatus of claim 19 further comprising a member in communication with at least a portion of the transdermal delivery device, the member supporting a transdermally-deliverable substance.

21. The apparatus of claim 20 wherein the member covers at least a portion of the transdermal delivery device.

22. The apparatus of claim 20 wherein the member includes a pad.

23. The apparatus of claim 20 wherein the transdermally-deliverable substance includes at least one of a pharmaceutical material, a protein, and a hormone.

24. The apparatus of claim 19 wherein the transdermal delivery device includes an ultrasonic emitter.

25. The apparatus of claim 19 wherein the credit-card-like housing includes a resilient portion.

26. The apparatus of claim 25 wherein the resilient portion supports at least a portion of the transdermal delivery device.